BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26487665)

  • 1. Interrelationship between electrocardiographic left ventricular hypertrophy, QT prolongation, and ischaemic stroke: the REasons for Geographic and Racial Differences in Stroke Study.
    O'Neal WT; Howard VJ; Kleindorfer D; Kissela B; Judd SE; McClure LA; Cushman M; Howard G; Soliman EZ
    Europace; 2016 May; 18(5):767-72. PubMed ID: 26487665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.
    Soliman EZ; Shah AJ; Boerkircher A; Li Y; Rautaharju PM
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):400-6. PubMed ID: 24762807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged corrected QT interval is predictive of future stroke events even in subjects without ECG-diagnosed left ventricular hypertrophy.
    Ishikawa J; Ishikawa S; Kario K
    Hypertension; 2015 Mar; 65(3):554-60. PubMed ID: 25534703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.
    Leigh JA; O'Neal WT; Soliman EZ
    Am J Cardiol; 2016 Jun; 117(11):1831-5. PubMed ID: 27067620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly.
    O'Neal WT; Almahmoud MF; Qureshi WT; Soliman EZ
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):1991-7. PubMed ID: 26153509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of left ventricular hypertrophy on QT prolongation and associated mortality.
    Haugaa KH; Bos JM; Borkenhagen EJ; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ
    Heart Rhythm; 2014 Nov; 11(11):1957-65. PubMed ID: 24956189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and ECG left ventricular hypertrophy.
    Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
    J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
    J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals.
    Lehtonen AO; Puukka P; Varis J; Porthan K; Tikkanen JT; Nieminen MS; Huikuri HV; Anttila I; Nikus K; Kähönen M; Jula A; Niiranen TJ
    J Hypertens; 2016 May; 34(5):959-66. PubMed ID: 26886566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension.
    Ahmad MI; Mujtaba M; Anees MA; Li Y; Soliman EZ
    Am J Cardiol; 2019 Sep; 124(6):886-891. PubMed ID: 31324356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
    Edison ES; Yano Y; Hoshide S; Kario K
    Am J Hypertens; 2015 Apr; 28(4):527-34. PubMed ID: 25267736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
    Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.